# Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

> **NCT01521364** · PHASE4 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 7 (actual)

## Conditions studied

- Multidrug-resistant Tuberculosis
- Extensively Drug-resistant Tuberculosis

## Interventions

- **DRUG:** Addition of different doses of clarithromycin.

## Key facts

- **NCT ID:** NCT01521364
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2013-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01521364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01521364, "Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01521364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*